INTRODUCTION {#s1}
============

An increase in sympathetic activity has been generally reported to have an intimate relation with the trigger and exacerbation of hypertension[@r1],[@r2],[@r3]^)^. Understanding hypertension and its mechanisms is very important in specialized cardiovascular physiotherapy[@r2], [@r4], [@r5]^)^. The development of hypertension is also associated with altered vascular reactivity and increased transmural pressure or stretch, which directly affects vascular smooth muscle cells[@r6],[@r7],[@r8],[@r9]^)^. The vascular smooth muscle is an important effector in the regulation of vasomotor tone[@r6], [@r8]^)^. In particular, a structural and functional impairment in the regulation of vascular smooth muscle contraction may be important in the pathogenesis and maintenance of increased peripheral vascular resistance in hypertension[@r5], [@r6], [@r8]^)^. The total peripheral resistance and the vascular reactivity to contractile agonists are increased in patients and experimental animal models with essential and secondary hypertension[@r5], [@r6], [@r8]^)^. Various experimental animal models have been used in the research of the pathophysiology of hypertension. Spontaneously hypertensive rats have been widely used as a pathophysiological animal model of genetically linked hypertension such as a human essential hypertension[@r8]^)^. The Dahl salt-sensitive rat was developed by selective breeding of rats for sensitivity or resistance to the hypertensive effects of a high salt diet[@r10]^)^, and the first experimental model of renovascular hypertension via a two-kidney, one clip maneuver demonstrated that renal ischemia is the cause of this disease[@r11]^)^. Specifically, the deoxycorticosterone acetate (DOCA)-salt hypertensive models, models of volume-expanded hypertension, were used to describe the natural history of malignant hypertension and the biochemical and hormonal characteristics of each stage of the disease[@r5],[@r6],[@r7], [@r12], [@r13]^)^. The purpose of this review was to collate the body of knowledge on DOCA-salt hypertension and the signal transduction involved in order to prepare a basic reference for cardiovascular physiotherapy research.

REVIEW {#s2}
======

Deoxycorticosterone acetate-salt hypertension and physiotherapy
---------------------------------------------------------------

One cause of hypertension is generally excessive salt consumption in conjunction with stress, which has a direct correlation with the DOCA-salt hypertensive model[@r1], [@r2], [@r5]^)^. In reality, when an increase in blood pressure occurs, the blood flow and volume are elevated by retention of water and sodium in the renal tubule, which is affected by the renin-angiotensin-aldosterone axis exposure to chronic stress[@r1], [@r2], [@r5], [@r6]^)^. In our experimental process, which was in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996), the animals underwent uninephrectomy via flank incision under intramuscular anesthesia[@r5],[@r6],[@r7]^)^ ([Fig. 1A](#fig_001){ref-type="fig"}Fig. 1.Schematic representation of deoxycorticosterone acetate-salt hypertension-induced responses and cardiovascular physiotherapy SD: Sprague-Dawley rats; Sham: sham-operated normotensive rats; DOCA: deoxycorticosterone acetate-salt hypertensive rats; N: nephrectomy; NTs: necrotic tissues; CCA: common carotid artery; SP and DP: systolic and diastolic blood pressure; CW: circulating water; WO: wash out; S: sample; PSS: physiological salt solution; \[Ca^2+^\]~i~: intracellular or cytosolic Ca^2+^; R340/380: ratio of fluorescence at the wavelengths of 340 and 380 nm; Kv current: voltage-dependent K^+^ current; PSS: physiological salt solution; Mesenteric a.: mesenteric artery; ET-1: endothelin-1; ET~A~: subtype A of endothelin receptor; ERK1/2: extracellular signal-regulated protein kinase 1 and 2; p38MAPK: p38 mitogen-activated protein kinase; SAPK/JNK: stress-activated protein kinase/c-Jun NH~2~-terminal kinase; MLCK: myosin light chain kinase; PKC: protein kinase C; ROCK: Rho-associated coiled coil-forming protein kinase; PI3 K: phosphatidylinositide-3 kinase; MAPK: mitogen-activated protein kinase; ET-Acu: electroacupuncture). The adrenal glands of both sham-operated rat and DOCA-salt hypertensive rat were not removed because adrenalectomy prevents the development of hypertension[@r14]^)^. After DOCA implantation surgery, DOCA-salt hypertensive rats received 0.9% NaCl plus 0.2% KCl drinking solution ([Table 1](#tbl_001){ref-type="table"}Table 1.The characteristics of deoxycorticosterone acetate-salt hypertensive ratsVariableNormotensive controlDOCA-salt hypertensive ratsReferencesBody weight (g)256 ± 18 to 437 ± 8204 ± 18 to 345 ± 8[@r12], [@r23], [@r43], [@r45], [@r47], [@r48], [@r50],[@r51],[@r52]^)^4 weeks SBP (mmHg)109 ± 4 to 141 ± 6184 ± 2 to 225 ± 6[@r5], [@r23], [@r43], [@r46],[@r47],[@r48],[@r49],[@r50],[@r51],[@r52]^)^MCFP (mmHg)6.7 ± 0.48.0 ± 0.4[@r50]^)^Heart rate (b/m)379 ± 13 to 426 ± 13370 ± 10 to 432 ± 15[@r50], [@r51]^)^Aortic weight (mg/cm)9.7 ± 0.2 to 11.2 ± 0.313.0 ± 0.6 to 12.9 ± 0.5[@r43], [@r52]^)^Wall thickness (μm)123 ± 2 to 142 ± 4149 ± 5 to 190 ± 3[@r43], [@r52]^)^Wall area (mm^2^)0.676 ± 0.0150.853 ± 0.033[@r43]^)^Wall-to-lumen ratio0.324 ± 0.0040.401 ± 0.016[@r43]^)^Media thickness (μm)10.8 ± 0.716.0 ± 1.0[@r44]^)^Media-lumen ratio (%)4.7 ± 0.37.4 ± 0.4[@r44]^)^Media CSA (μm^2^)8,230 ± 701 to 8,657 ± 62611,879 ± 1,327 to 14,475 ± 3,123[@r44], [@r45]^)^Aortic CSA (mm^2^)3.8 ± 0.64.8 ± 0.4[@r47]^)^Lumen diameter (μm)230.6 ± 6.7217.9 ± 12.5[@r43]^)^Femoral ring weight (mg)0.2154 ± 0.00560.2279 ± 0.0062[@r23]^)^Heart weight (g)0.995 ± 0.02 to 1.22 ± 0.091.329 ± 0.02 to 1.42 ± 0.07[@r44], [@r45]^)^Heart weight (mg/100 g BW)275.79 ± 6.68392.73 ± 14.51[@r23]^)^HW/BW (g/kg)2.91 ± 0.063.62 ± 0.09[@r43]^)^Heart weight (%/TBW)0.35 ± 0.020.51 ± 0.01[@r12]^)^LV weight (g)0.84 ± 0.061.02 ± 0.06[@r45]^)^RV weight (g)0.19 ± 0.010.21 ± 0.02[@r45]^)^VW-to-BW ratio (g/kg)3.3 ± 0.14.5 ± 0.1[@r49]^)^Kidney weight (g)3.7 ± 0.24.5 ± 0.3[@r45]^)^Kidney weight (%/TBW)0.65 ± 0.020.92 ± 0.04[@r12]^)^LKW/BW (g/kg)5.23 ± 0.108.20 ± 0.21[@r43]^)^Values are means ± SE. %/TBW indicates the % of total body weight; SBP: systolic blood pressure; MCFP: mean circulatory filling pressure; BW: body weight; HW: heart weight; VW-to-BW ratio: ventricular weight-to-body weight ratio; LKW: left kidney weight; CSA: cross-sectional area, [Fig. 1A](#fig_001){ref-type="fig"})[@r5],[@r6],[@r7]^)^. Induction of DOCA-salt hypertension is directly related to the increased vascular resistance that is widely known to be caused by an increase in vessel wall tension or other factors related to tension ([Fig. 1](#fig_001){ref-type="fig"}), such as mitogen-activated protein kinase (MAPK), protein tyrosine kinase (PTK), protein kinase C (PKC), phosphoinositide 3-kinase (PI3 K) and Rho-associated coiled coil-forming protein kinase (ROCK)[@r5],[@r6],[@r7],[@r8],[@r9]^)^. In particular, activation of MAPK is essential for the increase of muscle contraction and elevation of blood pressure[@r5],[@r6],[@r7]^)^. Meanwhile, several previous studies have indicated that electrical stimulation, massage, moxibustion, medicinal herbs such as Ligusticum wallichii and cordycepin and electroacupuncture may be used as alternative therapies for hypertension[@r1], [@r2], [@r15],[@r16],[@r17],[@r18],[@r19]^)^ in particular, but more systematic and scientific physiotherapy studies are still needed[@r4]^)^ ([Fig. 1F](#fig_001){ref-type="fig"}).

Abnormal vascular tension caused by stimuli and deoxycorticosterone acetate-salt hypertension
---------------------------------------------------------------------------------------------

It has been widely reported that hypertension is characterized by an increased responsiveness to vasoconstrictor agonists[@r5], [@r7], [@r12]^)^. In previous studies, catecholamine supersensitivity has preceded the development of hypertension[@r20]^)^. Specifically, the DOCA-salt hypertensive model is associated with marked changes that regulate vascular smooth muscle contraction due to increased adrenoceptor reactivity and activation of the sympathetic nervous system[@r21]^)^. Actually, the responsiveness of vasculature to norepinephrine is increased in DOCA-salt hypertension[@r22], [@r23]^)^. 5-Hydroxytryptamine markedly increases when contractions are stimulated in vascular smooth muscle strips isolated from animal models of experimental and/or genetic hypertension compared with normotensive animals[@r24], [@r25]^)^. Furthermore, one of our previous studies was the first to demonstrate that vasoconstrictors such as endothelin-1 (ET-1) decreased muscle contractility and the activity of p38 MAPK in aortic smooth muscle from DOCA-salt hypertensive rats compared with normotensive rats[@r5]^)^. These results imply that the MAPK pathway plays a central role in the control of muscle contraction and DOCA-salt hypertension[@r5], [@r22]^)^. Epidermal growth factor (EGF), one of the various growth factors, is an important regulator of cell regulation in a variety of cells[@r7], [@r26]^)^. EGF, a mitogenic polypeptide with a molecular weight of approximately 6 kD, is excreted in human urine in nanomolar quantities[@r26]^)^. It is also found in platelets, kidneys, and salivary glands[@r27],[@r28],[@r29]^)^. EGF, once released, can bind to its receptors found on vascular smooth muscle cells, in the submandibular gland, and in the rat liver[@r30]^)^. Although EGF acting via its tyrosine kinase receptor is widely recognized for its mitogenic and acid-inhibitory activity[@r31]^)^, it is now appreciated that this peptide can also modulate the contractility of a variety of smooth muscle cells and is related to the hypertension[@r7], [@r32], [@r33]^)^. In kinase-inactive mutants, EGF directly activates hypertension-related MAPK family members[@r34]^)^. The major findings of one of our previous studies were that EGF contracts aortic smooth muscle from DOCA-salt hypertensive rats but not sham-operated rats and that EGF increases the activity of MAPK in DOCA-salt hypertensive rats[@r7]^)^. These findings indicate that significant changes in EGF responsiveness occur during the development of hypertension and may allow for the development of a contractile response to EGF. Moreover, the EGF receptor is activated and is capable of interacting with proteins, including Grb2, guanine nucleotide exchange factor Sos, Shc, c-Src, Ras and Raf-1, leading to activation of the tyrosine kinase-dependent MAPK pathway[@r35]^)^. However, in one of our previous studies, inhibition of the PI3 K pathway, but not ROCK, attenuated EGF-induced muscle contraction and MAPK activation but not SAPK/JNK in DOCA-salt hypertension. Furthermore, understanding the mechanisms of growth factor-induced contraction should be a critical issue in cardiovascular physiotherapy[@r4]^)^. In this review, we have summarized DOCA-salt hypertension and its mechanisms ([Fig. 1](#fig_001){ref-type="fig"}). When scientific studies are performed in the fields of thermo-, hydro-, and electrotherapy, neurophysiotherapy, manipulative therapy, and therapeutic massage, we expect remarkable growth both in research and clinical applications in the field of cardiovascular physiotherapy[@r36],[@r37],[@r38],[@r39],[@r40],[@r41],[@r42]^)^ ([Fig. 1F](#fig_001){ref-type="fig"}).
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